Healthcare - Biotechnology - NASDAQ - US
$ 0.6701
-6.12 %
$ 25.9 M
Market Cap
-0.24
P/E
INCOME STATEMENT
0
REVENUE
-125 M
OPERATING INCOME
-118 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Athira Pharma, Inc.
| Revenue | 0 |
| Cost Of Revenue | 969 K |
| Gross Profit | -969 K |
| Operating Expenses | 125 M |
| Operating Income | -125 M |
| Other Expenses | -7.79 M |
| Net Income | -118 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.0 | 1.0 | 0.5 | 2.0 | 0 | 0 |
| Gross Profit | (1.0) | (1.0) | (0.5) | (2.0) | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 125.5 | 88.9 | 55.2 | 18.7 | 4.7 | 5.0 |
| Selling, General and Administrative Expenses | 33.3 | 32.6 | 21.2 | 6.7 | 1.7 | 1.4 |
| Research and Development Expenses | 93.8 | 61.5 | 42.8 | 13.3 | 3.8 | 3.6 |
| Operating Income | (125.5) | (104.0) | (64.0) | (20.0) | (5.4) | (5.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 24.3 | 3 K | 0.4 | 0.3 | 9 K |
| Total Other Income | 7.8 | 8.4 | 9.2 | 40 K | 0.3 | 88 K |
| Pre-Tax Income | (117.7) | (95.6) | (54.9) | (20.0) | (5.2) | (5.1) |
| NET INCOME | ||||||
| Tax Provision | 0 | (8.4) | (0.5) | (1.3) | (0.5) | 76 K |
| Net Income | (117.7) | (87.3) | (54.4) | (18.6) | (4.7) | (5.1) |
| EPS | 3.1 | 2.31 | 1.47 | 0.57 | 0.14 | 0.82 |